Skip to main content

Table 1 Characteristics of the study population with paired cervical and oral samples, stratified by human immunodeficiency virus (HIV) status

From: Cervical and oral human papillomavirus infection in women living with human immunodeficiency virus (HIV) and matched HIV-negative controls in Brazil

 HIV+ N = 115HIV- N = 139OR (CI)P
N (%)N (%)
Age cohort (years)
Mean42.1741.40.80.4
 18–3016 (13.9)31 (22.3)1 
 31–4036 (31.3)37 (26.6)1.93 (0.88–4.08)0.09
  > 4063 (54.8)71 (51.1)1.72 (0.84–3.36)0.12
School education (years)
  < 845 (39.1)26 (18.7)2.79 (1.55–5.00)0.0003
  ≥ 870 (60.9)113 (81.3)1
Marital status
 Married53 (46.1)68 (48.9)1 
 Unmarried45 (39.1)66 (47.5)1.14 (0.67–1.95)0.69
 Widowed17 (14.8)5 (3.6)0.22 (0.08–0.61)0.004
Skin color
 White48 (41.7)81 (58.2)1 
 Not white67 (58.2)58 (41.7)1.94 (1.17–3.24)0.009
Menarche (years)
  < 1356 (48.7)78 (56.1)1 
  ≥ 1359 (51.3)61 (43.9)1.34 (0.80–2.18)0.25
Age of sexual debut (years)
  < 1879 (68.7)78 (56.1)1.71 (1.02–2.89)0.04
  ≥ 1836 (31.3)61 (43.9)1 
Sexual partners (number)
 16 (5.2)24 (17.3)1 
 2–777 (66.9)82 (59)3.75 (1.43–9.28)0.004
  > 732 (27.9)33 (23.7)3.87 (1.36–10.68)0.007
Parity (number)
 03 (2.6)26 (18.7)1 
 1–259 (51.3)77 (55.4)6.64 (2.14–21.50)0.0006
  ≥ 353 (46.1)36 (25.9)12.76 (3.84–41.68)< 0.0001
History of cytology in the past three years
 Yes42 (36.5)73 (52.5)1 
 No73(63.5)66 (47.5)1.92 (1.15–3.20)0.01
Hormonal contraceptive use
 Yes20 (17.4)37 (26.6)1 
 No95 (82.6)102 (73.4)1.72 (0.93–3.19)0.08
Gynecologic infections
 Yes30 (26.1)29 (20.8)1 
 No85 (73.9)110 (79.1)1.33 (0.74–2.40)0.37
Cigarette smoking
 Yes30 (26.1)32 (23)1 
 No56 (48.7)85 (61.1)1.20.3
 Ex-smoker29 (25.2)22 (15.8)0.60.1
HIV diagnosis (years)
  < 573 (63.5)
 -1042 (36.5)
  > 100 (0)
HAART compliance
 Yes93 (80.9)
 No22 (19.1)
Current CD4 (cells/mm3)
  < 2003 (2.6)
 200–35017 (14.8)
  > 35095 (82.6)
Most recent viral load
 Undetectable99 (86.1)
 Detectable16 (13.9)
  1. HAART, highly active antiretroviral therapy; OR = Odds ratio; CI = confidence interval